Related references
Note: Only part of the references are listed.Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions
Li Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology
Wei Hou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells
Su-Wei Xu et al.
PHARMACOLOGICAL RESEARCH (2020)
Recent Advances in 1,2,4-Triazole Scaffolds as Antiviral Agents
S. A. El-Sebaey
CHEMISTRYSELECT (2020)
Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application
Jinfeng Shi et al.
FRONTIERS IN PHARMACOLOGY (2020)
Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells
Xi Chen et al.
THERANOSTICS (2020)
Exploring the Chemistry and Therapeutic Potential of Triazoles: A Comprehensive Literature Review
Ankit Jain et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
Design, synthesis and antitumor evaluation of novel celastrol derivatives
Manyi Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of Novel Celastrol Derivatives as Hsp90-Cdc37 Interaction Disruptors with Antitumor Activity
Na Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Molecular modulators of celastrol as the keystones for its diverse pharmacological activities
Sin Wi Ng et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Novel celastrol derivatives with improved selectivity and enhanced antitumour activity: Design, synthesis and biological evaluation
Sandra A. C. Figueiredo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds
Sandra A. C. Figueiredo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues
Muhamad Mustafa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Ramandeep Kaur et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Hsp90: Friends, clients and natural foes
Sharad Verma et al.
BIOCHIMIE (2016)
Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties
Fen Jiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
STRUCTURAL BIOLOGY Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase
Kliment A. Verba et al.
SCIENCE (2016)
Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis
Shyam Krishnan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Recent Researches in Triazole Compounds as Medicinal Drugs
C. -H. Zhou et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90-Cdc37, a Kinome Chaperone-Cochaperone, by Triterpene Celastrol
Sridhar Sreeramulu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Targeting HSP90 for cancer therapy
D. Mahalingam et al.
BRITISH JOURNAL OF CANCER (2009)
Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction
Tao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Non-steroidal aromatase inhibitors based on a biphenyl scaffold: Synthesis, in vitro SAR, and molecular modelling
Toby Jackson et al.
CHEMMEDCHEM (2008)
Heat-shock proteins as regulators of apoptosis
S Takayama et al.
ONCOGENE (2003)
Share Paper
